These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


781 related items for PubMed ID: 22932160

  • 1. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
    de Piano A, de Mello MT, Sanches Pde L, da Silva PL, Campos RM, Carnier J, Corgosinho F, Foschini D, Masquio DL, Tock L, Oyama LM, do Nascimento CM, Tufik S, Dâmaso AR.
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
    [Abstract] [Full Text] [Related]

  • 2. Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy.
    de Piano A, Tock L, Carnier J, Oyama LM, Oller do Nascimento CM, Martinz AC, Foschini D, Sanches PL, Ernandes RM, de Mello MT, Tufik S, Dâmaso AR.
    Metabolism; 2010 May; 59(5):613-9. PubMed ID: 19942238
    [Abstract] [Full Text] [Related]

  • 3. Aerobic plus resistance training improves bone metabolism and inflammation in adolescents who are obese.
    Campos RM, de Mello MT, Tock L, Silva PL, Masquio DC, de Piano A, Sanches PL, Carnier J, Corgosinho FC, Foschini D, Tufik S, Dâmaso AR.
    J Strength Cond Res; 2014 Mar; 28(3):758-66. PubMed ID: 24263653
    [Abstract] [Full Text] [Related]

  • 4. Aerobic training (AT) is more effective than aerobic plus resistance training (AT+RT) to improve anorexigenic/orexigenic factors in obese adolescents.
    Carnier J, de Mello MT, Ackel-DElia C, Corgosinho FC, Campos RM, Sanches Pde L, Masquio DC, Bueno CR, Ganen Ade P, Martins AC, Caranti DA, Tock L, Clemente AP, Tufik S, Dâmaso AR.
    Appetite; 2013 Oct; 69():168-73. PubMed ID: 23764241
    [Abstract] [Full Text] [Related]

  • 5. Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss.
    Dâmaso AR, de Piano A, Sanches PL, Corgosinho F, Tock L, Oyama LM, Tock L, do Nascimento CM, Tufik S, de Mello MT.
    Peptides; 2011 Jul; 32(7):1384-91. PubMed ID: 21641948
    [Abstract] [Full Text] [Related]

  • 6. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL, de Piano A, Campos RM, Carnier J, de Mello MT, Elias N, Fonseca FA, Masquio DC, da Silva PL, Corgosinho FC, Tock L, Oyama LM, Tufik S, Dâmaso AR.
    J Clin Lipidol; 2014 Jul; 8(3):265-72. PubMed ID: 24793347
    [Abstract] [Full Text] [Related]

  • 7. The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy.
    Campos RM, de Piano A, da Silva PL, Carnier J, Sanches PL, Corgosinho FC, Masquio DC, Lazaretti-Castro M, Oyama LM, Nascimento CM, Tock L, de Mello MT, Tufik S, Dâmaso AR.
    Endocrine; 2012 Aug; 42(1):146-56. PubMed ID: 22315014
    [Abstract] [Full Text] [Related]

  • 8. Aerobic plus resistance training was more effective in improving the visceral adiposity, metabolic profile and inflammatory markers than aerobic training in obese adolescents.
    Dâmaso AR, da Silveira Campos RM, Caranti DA, de Piano A, Fisberg M, Foschini D, de Lima Sanches P, Tock L, Lederman HM, Tufik S, de Mello MT.
    J Sports Sci; 2014 Aug; 32(15):1435-45. PubMed ID: 24730354
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN, Dogru T, Genc H, Celebi G, Aslan F, Gurel H, Kara M, Sertoglu E, Tapan S, Bagci S, Rizzo M, Sonmez A.
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.